RecruitingNot ApplicableNCT07549126
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability
Sponsor
Yale University
Enrollment
300 participants
Start Date
Apr 6, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Emergency department patient
- years of age or older
- Moderate to severe opioid use disorder
Exclusion Criteria3
- Under 18 years of age
- Pregnant
- Currently receiving medication for opioid use disorder
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNurse prompt to complete COWS under required documentation
Nurse receives prompt to complete COWS under required documentation
OTHERRefined EMBED CDS
Refined EMBED CDS
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07549126
Related Trials
GLP-1R Agonist Treatment for Opioid Use Disorder
NCT065484904 locations
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
NCT060677371 location
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
NCT066511779 locations
Adversity, Brain and Opioid Use Study
NCT063557781 location
Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery
NCT076932701 location